Source link : https://www.newshealth.biz/health-news/roflumilast-cream-effective-for-ad-in-phase-3-studies/
TOPLINE: Roflumilast cream 0.15% was well tolerated and significantly improved symptoms in adults and children with mild to moderate atopic dermatitis (AD) in two phase 3 trials. METHODOLOGY: Two randomized, parallel-group, double-blind, vehicle-controlled phase 3 trials, INTEGUMENT-1 (n = 654) and INTEGUMENT-2 (n = 683), enrolled patients aged ≥ 6 years with mild to moderate […]
Author : News Health
Publish date : 2024-09-19 08:51:48
Copyright for syndicated content belongs to the linked Source.